找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune; A. M. Diehl,N. Hayashi,T. Sauerbruch Book Sep 20071st edition Springer Sc

[复制链接]
查看: 29493|回复: 68
发表于 2025-3-21 19:10:51 | 显示全部楼层 |阅读模式
书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune
编辑A. M. Diehl,N. Hayashi,T. Sauerbruch
视频video
概述Interdisciplinary symposium bringing together basic science and clinical applications..Up-to-date research findings at the highest scientific level
丛书名称Falk Symposium
图书封面Titlebook: Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune;  A. M. Diehl,N. Hayashi,T. Sauerbruch Book Sep 20071st edition Springer Sc
描述.This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developments in the field of chronic hepatitis and its various entities. ..In recent decades we have learned how heterogeneous the clinical entity of chronic hepatitis has become. The liver, as the central organ of metabolism and detoxification, is more than ever a target of disease processes evolving from the spread of obesity in the western world. Apart from nonalcoholic steatohepatitis (NASH), alcoholic liver disease is still the most prevalent liver disease in the west. Alcohol-induced liver disease exhibits a broad clinical spectrum from alcoholic steatohepatitis to cirrhosis. Alcoholic hepatitis is a disease entity with a particular poor prognosis. Any liver disease of unknown cause is suspected as being drug-associated. Every new drug metabolized in the liver has the potential to damage the liver. Primary biliary cirrhosis has seen significant progress due to the identification of new risk factors
出版日期Book Sep 20071st edition
关键词apoptosis; hepatitis; hepatitis B; hepatology; immunosuppression; infection; liver; liver disease; liver tra
版次1
doihttps://doi.org/10.1007/978-1-4020-6523-1
copyrightSpringer Science+Business Media B.V. 2007
The information of publication is updating

书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune影响因子(影响力)




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune影响因子(影响力)学科排名




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune网络公开度




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune网络公开度学科排名




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune被引频次




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune被引频次学科排名




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune年度引用




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune年度引用学科排名




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune读者反馈




书目名称Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:46:25 | 显示全部楼层
发表于 2025-3-22 03:14:43 | 显示全部楼层
发表于 2025-3-22 04:40:46 | 显示全部楼层
Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune
发表于 2025-3-22 11:07:57 | 显示全部楼层
发表于 2025-3-22 14:42:32 | 显示全部楼层
c level.This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developmen
发表于 2025-3-22 17:49:07 | 显示全部楼层
Ralph-Johan Back,Joakim von Wrightof intermediate severity, characterized by overt injury and death of fatty hepatocytes. NASH may incite a sufficient fibrotic response to eventuate in cirrhosis. Hepatocellular carcinoma sometimes develops in cirrhotic livers.
发表于 2025-3-22 23:11:41 | 显示全部楼层
https://doi.org/10.1007/978-3-319-61599-8ic any form of acute or chronic liver disease; (4) it is the leading cause of failure in drug development and warning and withdrawls postmarketing. In this chapter I will concisely address some of the key clinical and pathophysiological points about DILI.
发表于 2025-3-23 03:56:55 | 显示全部楼层
Data Refinement and Simulations Many new HCV drugs are at the preclinical developmental schematically belong to four categores: novel IFN, alternatives to ribavirin, immune therapies, and specific and non-specific inhibitors of the HCV life cycle.
发表于 2025-3-23 08:11:33 | 显示全部楼层
John Derrick BSc, DPhil,Eerke Boiten Ir, PhDS are rare, nobody has ample experience with respect to characterization, diagnosis and treatment. This means that the following data are based on investigations performed in small patient numbers only, and the picture may change when more information becomes available.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 06:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表